<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[capital market and nasdaq stock market inc. Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/capital+market+and+nasdaq+stock+market+inc..html?i=5]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to capital market and nasdaq stock market inc.]]></description>
	<s:counts start="0" returned="10" found="108" />
	<language>en-us</language>
	<item>
		<title><![CDATA[NeoPharm Announces Stock Listing Transfer from NASDAQ Global Market to NASDAQ Capital Market]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_June_12/ai_n26671413]]></link>
		<description><![CDATA[LAKE BLUFF, Ill. -- NeoPharm, Inc. (NASDAQ: NEOL), announced today that it has received approval from the NASDAQ Listing Qualifications Staff to transfer the listing of its common stock from the NASDAQ Global Market to the NASDAQ Capital Market. The transfer will be effective as of the Market opening on...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 12 Jun 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/capital+market.html"><![CDATA[capital market]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Socket Moves Listing to NASDAQ Capital Market From NASDAQ Global Market]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200806/ai_n25498968]]></link>
		<description><![CDATA[Socket Mobile, Inc. (NASDAQ: SCKT), an innovative provider of mobile productivity products, today received approval from the NASDAQ Listing Qualifications Staff to transfer the listing of its common stock from the NASDAQ Global Market to the NASDAQ Capital Market. The transfer was effective as of the market opening on Tuesday,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 10 Jun 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/capital+market.html"><![CDATA[capital market]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Pet DRx To Begin Trading on Nasdaq Capital Market]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_May_28/ai_n25467033]]></link>
		<description><![CDATA[BRENTWOOD, Tenn. -- Pet DRx Corporation (OTCBB:PDXC)(OTCBB:PDXCW)(OTCBB:PDXCU) today announced that its common stock, warrants and units will commence trading on the Nasdaq Capital Market under the symbols "VETS," "VETSW," and "VETSU" respectively, when the market opens on May 29, 2008.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 28 May 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/capital+market.html"><![CDATA[capital market]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Nanogen Announces Stock Listing Transfer from NASDAQ Global Market to NASDAQ Capital Market]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_May_23/ai_n25452522]]></link>
		<description><![CDATA[SAN DIEGO -- Nanogen, Inc. (NASDAQ: NGEN), developer of in vitro diagnostic products, received approval from the NASDAQ Listing Qualifications Staff to transfer the listing of its common stock from the NASDAQ Global market to the NASDAQ Capital Market. The transfer is effective as of the Market opening on Tuesday,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 23 May 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/capital+market.html"><![CDATA[capital market]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Accentia Transfers Listing to NASDAQ Capital Market]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_May_23/ai_n25452623]]></link>
		<description><![CDATA[TAMPA, Fla. -- Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI) announced today that the Company received approval from the NASDAQ Stock Market for the transfer of the listing of its common stock from the NASDAQ Global Market to the NASDAQ Capital Market. The Company's common stock will be transferred to the NASDAQ Capital...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 23 May 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/capital+market.html"><![CDATA[capital market]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">NDAQ</category>
	</item>
	<item>
		<title><![CDATA[North American Scientific Regains Compliance on Nasdaq Capital Markets]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_May_22/ai_n25450274]]></link>
		<description><![CDATA[CHATSWORTH, Calif. -- North American Scientific, Inc. (the "Company") (Nasdaq: NASM) today announced that it received a letter from The Nasdaq Stock Market ("Nasdaq") dated May 15, 2008 providing notice that their bid price deficiency has been cured. As a result of regaining compliance with Nasdaq Marketplace Rules, The Nasdaq...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 22 May 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/capital+market.html"><![CDATA[capital market]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">NDAQ</category>
	</item>
	<item>
		<title><![CDATA[QSound Labs, Inc. Receives Nasdaq Staff Deficiency Letter About Continued Listing on the Nasdaq Capital Market]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200804/ai_n25161256]]></link>
		<description><![CDATA[QSound Labs, Inc. (NASDAQ: QSND) today announced that on April 11, 2008 the Company received from The Nasdaq Stock Market a letter indicating that the Company is not currently in compliance with the stockholders' equity, market value of publicly held shares and total asset and revenue requirements for continued listing...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 16 Apr 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/capital+market.html"><![CDATA[capital market]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Natural Health Trends Corp.  Will Apply for Transfer to Nasdaq Capital Market]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200804/ai_n25136311]]></link>
		<description><![CDATA[Natural Health Trends Corp. (NASDAQ: BHIP) announced today that it will apply to transfer its Nasdaq listing from the Nasdaq Global Market to the Nasdaq Capital Market. The Company no longer meets the continued listing standards for the Nasdaq Global Market because, as reported in its Form 10-K for the...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 08 Apr 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/capital+market.html"><![CDATA[capital market]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Syntroleum to Transfer to NASDAQ Capital Market]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_March_31/ai_n24963219]]></link>
		<description><![CDATA[Previously Announced Quarterly Investor Conference Call Scheduled for April 2]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 31 Mar 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/capital+market.html"><![CDATA[capital market]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Initial Trading of RXi Pharmaceuticals Begins Today on the NASDAQ Capital Market Under Symbol RXII]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_March_12/ai_n24387232]]></link>
		<description><![CDATA[WORCESTER, Mass. -- RXi Pharmaceuticals (NASDAQ: RXII), a biopharmaceutical company pursuing the development and potential commercialization of proprietary therapeutics based on RNA interference RNAi for the treatment of human diseases, initiated trading today on the NASDAQ Capital Market.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 12 Mar 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/capital+market.html"><![CDATA[capital market]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">NDAQ</category>
	</item>
</channel>
</rss>
